C4 Therapeutics, Inc. (CCCC)
2.16
+0.04
(+1.89%)
USD |
NASDAQ |
Feb 20, 16:00
2.16
0.00 (0.00%)
After-Hours: 20:00
C4 Therapeutics Total Assets (Quarterly) : 265.49M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Biogen, Inc. | 29.44B |
| Pfizer Inc. | -- |
| ACADIA Pharmaceuticals, Inc. | 1.331B |
| Agenus, Inc. | 233.89M |
| Alnylam Pharmaceuticals, Inc. | 5.026B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 111.08M |
| Shareholders Equity (Quarterly) | 154.41M |
| Debt to Equity Ratio | 0.3981 |
| Current Ratio | 5.755 |
| Net Debt Paydown Yield | 0.84% |